SKYX director granted 26,500 shares and options
SKYX Platforms Corp. director Nancy DiMattia received new equity compensation consisting of common stock and stock options.
Rhea-AI Filing Summary
SKYX Platforms Corp. director Nancy DiMattia received new equity compensation consisting of common stock and stock options. She was granted 26,500 shares of restricted stock that vested immediately under the non-employee director compensation program, increasing her direct holdings to 137,770 common shares.
She was also granted stock options for 26,500 shares of common stock at an exercise price of $1.12 per share, expiring on March 31, 2031. These options vest in twelve equal monthly installments beginning April 30, 2026. In addition, she holds previously granted options with exercise prices of $12.34, $3.28, $1.09, and $1.26 per share, each tied to specific future expiration dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 53,000 shares
Grant/Award
6 txns
Insider
DiMattia Nancy
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 26,500 | $0.00 | $0.00 |
| Grant/Award | Common Stock, no par value | 26,500 | $0.00 | $0.00 |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 114,000 contracts for 87,500 underlying shares (Direct);
Common Stock, no par value — 137,770 shares (Direct)
Footnotes (2)
- F1. Represents shares of restricted stock, which vested immediately upon grant and were granted pursuant to the non-employee director compensation program.
- F2. Options vest in twelve equal monthly installments, on the last day of each month, beginning on April 30, 2026. These options were granted pursuant to the non-employee director compensation program.
Key Figures
Restricted stock grant: 26,500 shares
New option grant size: 26,500 shares
New option exercise price: $1.12 per share
+5 more
8 metrics
Restricted stock grant
26,500 shares
Restricted stock vested immediately on March 31, 2026
New option grant size
26,500 shares
Stock options on common stock granted March 31, 2026
New option exercise price
$1.12 per share
Exercise price for options expiring March 31, 2031
Shares held after grant
137,770 shares
Total direct common stock holdings after March 31, 2026 award
Existing option exercise price
$12.34 per share
Existing option tranche expiring March 11, 2027 on 8,000 shares
Existing option exercise price
$3.28 per share
Existing option tranche expiring April 5, 2028 on 26,500 shares
Existing option exercise price
$1.09 per share
Existing option tranche expiring April 4, 2029 on 26,500 shares
Existing option exercise price
$1.26 per share
Existing option tranche expiring March 27, 2030 on 26,500 shares
Key Terms
restricted stock, non-employee director compensation program, Stock Option (right to buy), vest in twelve equal monthly installments, +1 more
5 terms
restricted stock financial
"Represents shares of restricted stock, which vested immediately upon grant"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
non-employee director compensation program financial
"were granted pursuant to the non-employee director compensation program"
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
vest in twelve equal monthly installments financial
"Options vest in twelve equal monthly installments, on the last day of each month"
exercise price financial
"conversion_or_exercise_price": "1.1200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SKYX director Nancy DiMattia report in this Form 4?
Nancy DiMattia reported receiving equity compensation from SKYX Platforms Corp., including 26,500 restricted shares that vested immediately and 26,500 stock options, all as part of the non-employee director compensation program on March 31, 2026.
What are the key terms of Nancy DiMattia’s new SKYX stock options?
Nancy DiMattia received options for 26,500 SKYX shares at an exercise price of $1.12 per share. These options expire on March 31, 2031 and vest in twelve equal monthly installments starting April 30, 2026 under the director compensation program.
Are Nancy DiMattia’s new SKYX equity awards open-market purchases?
No, the transactions are compensation-related grants, not open-market purchases. The Form 4 shows restricted stock and stock option awards granted at no cash cost as part of SKYX’s non-employee director compensation program, rather than discretionary market buying.
What existing SKYX stock options does Nancy DiMattia hold?
Nancy DiMattia holds previously granted stock options on SKYX common stock with exercise prices of $12.34, $3.28, $1.09, and $1.26 per share. These options cover specified share amounts and have expiration dates from March 2027 through March 2030.
Does this SKYX Form 4 show any stock sales by Nancy DiMattia?
The Form 4 does not show any sales. It reports acquisitions of restricted stock and stock options as compensation awards, along with existing option holdings, with no open-market dispositions or other sales transactions disclosed in this data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
